A 'fit' microbiota to potentiate cancer immunotherapy

Genome Medicine

Volumn 7, Issue 1, 2015, Pages

  Rescigno, Maria ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; POLYSACCHARIDE; POLYSACCHARIDE A; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; CANCER IMMUNOTHERAPY; CANCER RESEARCH; CLINICAL PRACTICE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MICROBIAL DIVERSITY; MICROFLORA; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR MICROENVIRONMENT; ANIMAL; ANIMAL MODEL; CARCINOGENESIS; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; MICROBIOLOGY; MOUSE; NEOPLASMS; PROCEDURES;

ANIMALS; CARCINOGENESIS; HUMANS; IMMUNOTHERAPY; MICE; MICROBIOTA; MODELS, ANIMAL; NEOPLASMS;

EID: 84952883106     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-015-0256-x     Document Type: Article

References (10)

1. Vetizou M, Pitt JM, Daillere R, Lepage P, Waldschmitt N, Flament C, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350:1079-84.
2. Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350:1084-9.
3. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336:1268-73.
4. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59-65.
5. Backhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17:690-703.
6. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107:11971-5.
7. Postow MA, Chesney J, Pavlick AC, Robert C, Grossmann K, McDermott D, et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med. 2015;372:2006-17.
8. Fransen F, Zagato E, Mazzini E, Fosso B, Manzari C, El Aidy S, et al. BALB/c and C57BL/6 mice differ in polyreactive IgA abundance, which impacts the generation of antigen-specific IgA and microbiota diversity. Immunity. 2015;43:527-40.
9. Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342:967-70.
10. Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342:971-6.